相似文献
1
FK 506 versus cyclosporine in pediatric liver transplantation.
Transplant Proc. 1991 Dec;23(6):3010-5.
2
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
Transplant Proc. 1991 Dec;23(6):2977-83.
3
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Transplant Proc. 1995 Feb;27(1):45-9.
4
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Transplant Proc. 1993 Apr;25(2):1988-9.
5
FK 506 rescue therapy: early conversion improves efficacy.
Transplant Proc. 1993 Apr;25(2):1990-1.
6
Therapy with FK 506 in pediatric liver recipients.
Transplant Proc. 1994 Feb;26(1):152-3.
7
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Transplant Proc. 1993 Feb;25(1 Pt 1):679-88.
8
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
Z Gastroenterol. 1995 Oct;33(10):624-5.
9
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
Transplant Proc. 1998 Jun;30(4):1399-400. doi: 10.1016/s0041-1345(98)00288-7.
10
引用本文的文献
1
Immunosuppressive drugs in paediatric liver transplantation.
Paediatr Drugs. 2001;3(1):43-60. doi: 10.2165/00128072-200103010-00004.
2
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Transplantation. 2000 Aug 27;70(4):617-25. doi: 10.1097/00007890-200008270-00015.
3
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):367-70. doi: 10.1007/BF03192295.
4
Small intestinal transplantation for irreversible intestinal failure in children.
Dig Dis Sci. 1997 Oct;42(10):1997-2008. doi: 10.1023/a:1018896112360.
5
Parvovirus B19 infection in pediatric transplant patients.
Transplantation. 1993 Oct;56(4):835-8. doi: 10.1097/00007890-199310000-00011.
6
Early tolerance in pediatric liver allograft recipients.
J Pediatr Surg. 1994 Jun;29(6):754-6. doi: 10.1016/0022-3468(94)90362-x.
7
Two-year experience with FK 506 in pediatric patients.
Transplant Proc. 1993 Feb;25(1 Pt 1):619-21.
8
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Liver and kidney transplantation in children receiving cyclosporin A and steroids.
J Pediatr. 1982 May;100(5):681-6. doi: 10.1016/s0022-3476(82)80564-7.
2
Indications for pediatric liver transplantation.
J Pediatr. 1987 Dec;111(6 Pt 2):1039-45. doi: 10.1016/s0022-3476(87)80053-7.
3
Liver transplantation therapy for children: Part 1.
J Pediatr Gastroenterol Nutr. 1988 Mar-Apr;7(2):157-66. doi: 10.1097/00005176-198803000-00001.
4
Liver transplantation, including the concept of reduced-size liver transplants in children.
Ann Surg. 1988 Oct;208(4):410-20. doi: 10.1097/00000658-198810000-00003.
5
Pediatric liver transplantation: a 3-year experience.
J Pediatr Surg. 1989 Jan;24(1):77-82. doi: 10.1016/s0022-3468(89)80306-9.
6
FK 506 for liver, kidney, and pancreas transplantation.
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
7
Orthotopic liver transplantation in dogs receiving FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):64-7.
8
Liver transplantation in children.
Ann Surg. 1991 Jan;213(1):48-57. doi: 10.1097/00000658-199101000-00009.
9
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
10
Use of FK 506 in pediatric patients.
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.
Zotero 插件